V5 effects include significant improvement of clinical outcomes for hepatitis B treatment, hepatitis C treatment, and recently, for tuberculosis treatment, including drug resistant tuberculosis (MDR-TB and XDR-TB) and TB and HIV co-infection. V5 is an orally delivered
formulation, manufactured as a simple tablet. It has been postulated that V5 effects on hepatitis B, hepatitis C, and tuberculosis is dependent upon an immunomodulatory effect of the product.